Comments
Loading...

Teladoc Health Analyst Ratings

TDOCNYSE
Logo brought to you by Benzinga Data
$8.49
0.11.19%
At close: -
$8.54
0.050.59%
After Hours: 7:36 PM EDT
Consensus Rating1
Neutral
Highest Price Target1
$40.00
Lowest Price Target1
$8.00
Consensus Price Target1
$18.78

Teladoc Health Analyst Ratings and Price Targets | NYSE:TDOC | Benzinga

Teladoc Health Inc has a consensus price target of $18.78 based on the ratings of 33 analysts. The high is $40 issued by DA Davidson on October 25, 2022. The low is $8 issued by TD Cowen on October 31, 2024. The 3 most-recent analyst ratings were released by Goldman Sachs, Piper Sandler, and Goldman Sachs on March 3, 2025, February 27, 2025, and February 18, 2025, respectively. With an average price target of $13.67 between Goldman Sachs, Piper Sandler, and Goldman Sachs, there's an implied 60.03% upside for Teladoc Health Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Dec 24
2
Jan
2
2
Feb
1
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
2.7
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Goldman Sachs
Piper Sandler
B of A Securities
RBC Capital
Oppenheimer

1calculated from analyst ratings

Analyst Ratings for Teladoc Health

Buy NowGet Alert
03/03/2025Buy Now52.22%Goldman Sachs
David Roman37%
$16 → $13MaintainsBuyGet Alert
02/27/2025Buy Now—Needham
Ryan MacDonald58%
—ReiteratesHold → HoldGet Alert
02/27/2025Buy Now40.52%Piper Sandler
Jessica Tassan39%
$13 → $12MaintainsOverweightGet Alert
02/18/2025Buy Now87.35%Goldman Sachs
David Roman37%
$14 → $16MaintainsBuyGet Alert
02/12/2025Buy Now58.08%B of A Securities
Allen Lutz64%
$11.5 → $13.5MaintainsNeutralGet Alert
02/06/2025Buy Now34.66%B of A Securities
Allen Lutz64%
$10.5 → $11.5MaintainsNeutralGet Alert
01/24/2025Buy Now40.52%RBC Capital
Sean Dodge49%
$11 → $12MaintainsOutperformGet Alert
01/24/2025Buy Now40.52%Oppenheimer
Michael Wiederhorn61%
$14 → $12MaintainsOutperformGet Alert
12/04/2024Buy Now52.22%Piper Sandler
Jessica Tassan39%
$11 → $13ReiteratesOverweight → OverweightGet Alert
11/15/2024Buy Now63.93%Goldman Sachs
David Roman37%
→ $14Initiates → BuyGet Alert
11/01/2024Buy Now40.52%Deutsche Bank
George Hill62%
$10 → $12MaintainsHoldGet Alert
10/31/2024Buy Now40.52%Barclays
Steve Valiquette53%
$10 → $12MaintainsOverweightGet Alert
10/31/2024Buy Now-6.32%TD Cowen
Charles Rhyee37%
$9 → $8MaintainsHoldGet Alert
10/09/2024Buy Now17.1%RBC Capital
Sean Dodge49%
$9 → $10MaintainsOutperformGet Alert
10/08/2024Buy Now5.39%Evercore ISI Group
Elizabeth Anderson47%
$8 → $9MaintainsIn-LineGet Alert
09/17/2024Buy Now17.1%Jefferies
Glen Santangelo50%
$8 → $10MaintainsHoldGet Alert
08/26/2024Buy Now5.39%JP Morgan
Lisa Gill58%
$16 → $9MaintainsNeutralGet Alert
08/20/2024Buy Now17.1%Cantor Fitzgerald
Sarah James49%
$10 → $10ReiteratesOverweight → OverweightGet Alert
08/06/2024Buy Now17.1%Piper Sandler
Jessica Tassan39%
$25 → $10MaintainsOverweightGet Alert
08/02/2024Buy Now17.1%Deutsche Bank
George Hill62%
$15 → $10MaintainsHoldGet Alert
08/02/2024Buy Now17.1%Truist Securities
Jailendra Singh38%
$15 → $10MaintainsHoldGet Alert
08/01/2024Buy Now—Needham
Ryan MacDonald58%
—Reiterates → HoldGet Alert
08/01/2024Buy Now5.39%TD Cowen
Charles Rhyee37%
$15 → $9MaintainsHoldGet Alert
08/01/2024Buy Now5.39%RBC Capital
Sean Dodge49%
$18 → $9MaintainsOutperformGet Alert
08/01/2024Buy Now17.1%Barclays
Steve Valiquette53%
$20 → $10MaintainsOverweightGet Alert
08/01/2024Buy Now5.39%Stifel
David Grossman63%
$16 → $9MaintainsHoldGet Alert
08/01/2024Buy Now-6.32%DA Davidson
Gil Luria56%
$12 → $8MaintainsNeutralGet Alert
08/01/2024Buy Now99.06%Canaccord Genuity
Richard Close46%
$25 → $17MaintainsBuyGet Alert
08/01/2024Buy Now99.06%Oppenheimer
Michael Wiederhorn61%
$21 → $17MaintainsOutperformGet Alert
07/09/2024Buy Now17.1%Evercore ISI Group
Elizabeth Anderson47%
$14 → $10MaintainsIn-LineGet Alert
05/21/2024Buy Now87.35%JP Morgan
Lisa Gill58%
$19 → $16MaintainsNeutralGet Alert
05/20/2024Buy Now63.93%Jefferies
Glen Santangelo50%
$16 → $14MaintainsHoldGet Alert
05/14/2024Buy Now58.08%B of A Securities
Allen Lutz64%
$16.5 → $13.5MaintainsNeutralGet Alert
04/29/2024Buy Now75.64%Wells Fargo
Stephen Baxter54%
$17 → $15MaintainsEqual-WeightGet Alert
04/26/2024Buy Now145.9%Oppenheimer
Michael Wiederhorn61%
$26 → $21MaintainsOutperformGet Alert
04/26/2024Buy Now75.64%TD Cowen
Charles Rhyee37%
$16 → $15MaintainsHoldGet Alert
04/26/2024Buy Now63.93%Evercore ISI Group—$15 → $14MaintainsIn-LineGet Alert
04/26/2024Buy Now110.77%RBC Capital
Sean Dodge49%
$25 → $18MaintainsOutperformGet Alert
04/26/2024Buy Now87.35%Stifel
David Grossman63%
$21 → $16MaintainsHoldGet Alert
04/26/2024Buy Now134.19%Barclays
Steve Valiquette53%
$25 → $20MaintainsOverweightGet Alert
04/26/2024Buy Now192.74%Canaccord Genuity
Richard Close46%
$28 → $25MaintainsBuyGet Alert
04/26/2024Buy Now—Needham
Ryan MacDonald58%
—Reiterates → HoldGet Alert
04/05/2024Buy Now—Needham
Ryan MacDonald58%
—Reiterates → HoldGet Alert
03/06/2024Buy Now99.06%Truist Securities
Jailendra Singh38%
$23 → $17MaintainsHoldGet Alert
02/29/2024Buy Now157.61%Cantor Fitzgerald
Sarah James49%
→ $22Initiates → OverweightGet Alert
02/26/2024Buy Now99.06%Leerink Partners
Michael Cherny79%
→ $17Initiates → Market PerformGet Alert
02/21/2024Buy Now110.77%DA Davidson
Gil Luria56%
$22 → $18MaintainsNeutralGet Alert
02/21/2024Buy Now122.48%Citigroup
Daniel Grosslight42%
$21 → $19MaintainsNeutralGet Alert
02/21/2024Buy Now192.74%RBC Capital
Sean Dodge49%
$30 → $25MaintainsOutperformGet Alert
02/21/2024Buy Now192.74%Barclays
Steve Valiquette53%
$26 → $25MaintainsOverweightGet Alert
02/21/2024Buy Now192.74%Piper Sandler
Jessica Tassan39%
$30 → $25MaintainsOverweightGet Alert
02/21/2024Buy Now227.87%Canaccord Genuity
Richard Close46%
$34 → $28MaintainsBuyGet Alert
11/17/2023Buy Now122.48%JP Morgan
Lisa Gill58%
$33 → $19MaintainsNeutralGet Alert
10/25/2023Buy Now251.29%RBC Capital
Sean Dodge49%
$35 → $30MaintainsOutperformGet Alert
10/25/2023Buy Now204.45%Oppenheimer
Michael Wiederhorn61%
$35 → $26MaintainsOutperformGet Alert
10/23/2023Buy Now145.9%Citigroup
Daniel Grosslight42%
$29 → $21MaintainsNeutralGet Alert
10/20/2023Buy Now145.9%Citigroup
Daniel Grosslight42%
$29 → $21MaintainsNeutralGet Alert
09/25/2023Buy Now227.87%Truist Securities
Jailendra Singh38%
→ $28ReiteratesHold → HoldGet Alert
07/26/2023Buy Now227.87%Stephens & Co.
Jeff Garro37%
→ $28ReiteratesEqual-Weight → Equal-WeightGet Alert
07/26/2023Buy Now309.84%RBC Capital
Sean Dodge49%
→ $35ReiteratesOutperform → OutperformGet Alert
07/26/2023Buy Now239.58%Citigroup
Daniel Grosslight42%
$31 → $29MaintainsNeutralGet Alert
07/26/2023Buy Now216.16%Credit Suisse
Jonathan Yong64%
→ $27ReiteratesNeutral → NeutralGet Alert
04/28/2023Buy Now239.58%Deutsche Bank
George Hill62%
$27 → $29MaintainsHoldGet Alert
04/27/2023Buy Now263%Citigroup
Daniel Grosslight42%
$30 → $31MaintainsNeutralGet Alert
04/27/2023Buy Now309.84%RBC Capital
Sean Dodge49%
→ $35Reiterates → OutperformGet Alert
04/27/2023Buy Now216.16%Credit Suisse
Jonathan Yong64%
→ $27Reiterates → NeutralGet Alert
04/27/2023Buy Now239.58%Barclays
Steve Valiquette53%
$28 → $29MaintainsEqual-WeightGet Alert
04/12/2023Buy Now192.74%Stephens & Co.
Jeff Garro37%
→ $25Initiates → Equal-WeightGet Alert
03/10/2023Buy Now216.16%Credit Suisse
Jonathan Yong64%
$30 → $27MaintainsNeutralGet Alert
03/06/2023Buy Now321.55%Canaccord Genuity
Richard Close46%
$40 → $36MaintainsBuyGet Alert
03/06/2023Buy Now169.32%Wells Fargo
Stan Berenshteyn42%
$28 → $23MaintainsEqual-WeightGet Alert
02/28/2023Buy Now251.29%Citigroup
Daniel Grosslight42%
$33 → $30MaintainsNeutralGet Alert
02/27/2023Buy Now216.16%Deutsche Bank
George Hill62%
$31 → $27MaintainsHoldGet Alert
02/27/2023Buy Now286.42%JP Morgan
Lisa Gill58%
$35 → $33MaintainsNeutralGet Alert
02/23/2023Buy Now309.84%Oppenheimer
Michael Wiederhorn61%
$37 → $35MaintainsOutperformGet Alert
02/23/2023Buy Now309.84%RBC Capital
Sean Dodge49%
→ $35Reiterates → OutperformGet Alert
02/23/2023Buy Now298.13%SVB Leerink
Stephanie Davis40%
→ $34UpgradeMarket Perform → OutperformGet Alert
01/19/2023Buy Now333.26%Oppenheimer
Colin Rusch53%
$45 → $37MaintainsOutperformGet Alert
01/18/2023Buy Now227.87%Barclays
Marc Solecitto61%
$32 → $28MaintainsEqual-WeightGet Alert
12/13/2022Buy Now286.42%Citigroup
Daniel Grosslight42%
$36 → $33MaintainsNeutralGet Alert
10/31/2022Buy Now251.29%Credit Suisse
Jonathan Yong64%
$35 → $30MaintainsNeutralGet Alert
10/27/2022Buy Now321.55%Citigroup
Daniel Grosslight42%
$38 → $36MaintainsNeutralGet Alert
10/27/2022Buy Now274.71%Barclays
Steve Valiquette53%
$33 → $32MaintainsEqual-WeightGet Alert
10/25/2022Buy Now368.38%DA Davidson
Robert Simmons54%
$45 → $40MaintainsBuyGet Alert
10/24/2022Buy Now—Guggenheim
Sandy Draper72%
—UpgradeSell → NeutralGet Alert
10/21/2022Buy Now239.58%Truist Securities
Jailendra Singh38%
$35 → $29MaintainsHoldGet Alert
10/11/2022Buy Now286.42%Barclays
Steve Valiquette53%
$40 → $33MaintainsEqual-WeightGet Alert
09/28/2022Buy Now309.84%RBC Capital
Sean Dodge49%
$53 → $35MaintainsOutperformGet Alert
09/27/2022Buy Now263%Deutsche Bank
George Hill62%
$34 → $31MaintainsHoldGet Alert
09/16/2022Buy Now—Keybanc
Scott Schoenhaus43%
—Initiates → Sector WeightGet Alert
09/07/2022Buy Now309.84%Truist Securities
Jailendra Singh38%
→ $35Initiates → HoldGet Alert
08/17/2022Buy Now192.74%Guggenheim
Sandy Draper72%
→ $25DowngradeNeutral → SellGet Alert
08/12/2022Buy Now426.93%DA Davidson
Robert Simmons54%
→ $45Initiates → BuyGet Alert
08/02/2022Buy Now309.84%Berenberg
Ravi Misra33%
$42 → $35DowngradeBuy → HoldGet Alert
08/02/2022Buy Now298.13%Cowen & Co.
Charles Rhyee37%
$58 → $34DowngradeOutperform → Market PerformGet Alert
07/28/2022Buy Now321.55%Goldman Sachs
Cindy Motz28%
$55 → $36DowngradeBuy → NeutralGet Alert
07/28/2022Buy Now368.38%Barclays
Steve Valiquette53%
$42 → $40MaintainsEqual-WeightGet Alert
07/28/2022Buy Now—Needham
Ryan MacDonald58%
—DowngradeBuy → HoldGet Alert
07/28/2022Buy Now368.38%Piper Sandler
Jessica Tassan39%
$42 → $40MaintainsOverweightGet Alert
07/28/2022Buy Now544.03%Oppenheimer
Michael Wiederhorn61%
$65 → $55MaintainsOutperformGet Alert

FAQ

Q

What is the target price for Teladoc Health (TDOC) stock?

A

The latest price target for Teladoc Health (NYSE:TDOC) was reported by Goldman Sachs on March 3, 2025. The analyst firm set a price target for $13.00 expecting TDOC to rise to within 12 months (a possible 52.22% upside). 43 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Teladoc Health (TDOC)?

A

The latest analyst rating for Teladoc Health (NYSE:TDOC) was provided by Goldman Sachs, and Teladoc Health maintained their buy rating.

Q

When was the last upgrade for Teladoc Health (TDOC)?

A

The last upgrade for Teladoc Health Inc happened on February 23, 2023 when SVB Leerink raised their price target to $34. SVB Leerink previously had a market perform for Teladoc Health Inc.

Q

When was the last downgrade for Teladoc Health (TDOC)?

A

The last downgrade for Teladoc Health Inc happened on August 17, 2022 when Guggenheim changed their price target from N/A to $25 for Teladoc Health Inc.

Q

When is the next analyst rating going to be posted or updated for Teladoc Health (TDOC)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Teladoc Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Teladoc Health was filed on March 3, 2025 so you should expect the next rating to be made available sometime around March 3, 2026.

Q

Is the Analyst Rating Teladoc Health (TDOC) correct?

A

While ratings are subjective and will change, the latest Teladoc Health (TDOC) rating was a maintained with a price target of $16.00 to $13.00. The current price Teladoc Health (TDOC) is trading at is $8.54, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch